🇺🇸 FDA
Patent

US 9969719

Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

granted A61PA61P35/00A61P35/02

Quick answer

US patent 9969719 (Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug) held by Medshine Discovery Inc. expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00